The Medical Weight Loss and GLP-1 Treatment Program can fulfill these requirements while providing meaningful metabolic progress
GLP-1 medications like Wegovy and Mounjaro dont directly lower blood sugar the way insulin doesbut they do change how your body manages food, energy, and digestion
So once you get into it, you can stay long-term [on the] treatment." Novo Nordisk is also experimenting with its own version of the treatment, combining the GLP-1 component Semaglutide with amylin analog Cagrilintide in a candidate called CagriSema
A 2017 RCT investigating liposomal glutathione (500 mg daily for eight weeks) in patients with fatty liver disease found improvements in oxidative stress markers and liver enzyme levels
For a broader comparison between the two major GLP-1 medications, see our semaglutide versus tirzepatide comparison
Foundayo introduces an oral GLP-1 option, available at any time without special storage requirements